People · Operator

L. John Wilkerson

Named in public records as an officer, director or promoter · active 2010–2016 · Other Health Care

2
Companies
4
Filings
$18.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
HCPlexus, Inc.Other Health CareSeries A$10.0M$201.8M2010
Rio Grande Neurosciences, Inc.Other Health CareSeed$8.9M$20.5M2015
Operator network

L. John Wilkerson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Zubeen Shroff · 5 companies · 1 sharedZubeen ShroffDavid Azad · 2 companies · 1 sharedDavid AzadBob John Merold · 1 companies · 1 sharedBob John MeroldDavid Shrier · 1 companies · 1 sharedDavid ShrierBlake Gurfein · 2 companies · 1 sharedBlake GurfeinStephen Juelsgaard · 2 companies · 1 sharedStephen JuelsgaardSteven Gluckstern · 2 companies · 1 sharedSteven GlucksternSteven M. Gluckstern · 2 companies · 1 sharedSteven M. Gluckst…Blake M. Gurfein · 1 companies · 1 sharedBlake M. GurfeinJohn L Wilkerson · 1 companies · 1 sharedJohn L WilkersonSean Hagberg · 1 companies · 1 sharedSean HagbergSean M. Hagberg · 1 companies · 1 sharedSean M. HagbergStephen M. Juelsgaard · 1 companies · 1 sharedStephen M. Juelsg…HCPlexus, Inc. · $10.0M raisedHCPlexus, Inc.Rio Grande Neurosciences, Inc. · $8.9M raisedRio Grande Neuroscien…L. John WilkersonLW
L. John Wilkerson Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside L. John Wilkerson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Zubeen Shroff15
Blake Gurfein12
Stephen Juelsgaard12
Steven M. Gluckstern12
David Azad12
Steven Gluckstern12
David Shrier11
Bob John Merold11
Sean Hagberg11
Blake M. Gurfein11
Sean M. Hagberg11
Stephen M. Juelsgaard11
John L Wilkerson11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.